The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration
Open accessAbstract
BACKGROUND: Nephropathy induced by exposure to radiocontrast agents, a possible complication of percutaneous coronary interventions, is associated with significant in-hospital and long-term morbidity and mortality. Patients with preexisting renal failure are at particularly high risk. We investigated the role of hemofiltration, as compared with isotonic-saline hydration, in preventing contrast-agent-induced nephropathy in patients with renal failure. METHODS: We studied 114 consecutive patients with chronic renal failure (serum creatinine concentration, >2 mg per deciliter [176.8 micromol per liter]) who were undergoing coronary interventions. We randomly assigned them to either hemofiltration in an intensive care unit (ICU) (58 patients, with a mean [+/-SD] serum creatinine concentration of 3.0+/-1.0 mg per deciliter [265.2+/-88.4 micromol per liter]) or isotonic-saline hydration at a rate of 1 ml per kilogram of body weight per hour given in a step-down unit (56 patients, with a mean serum creatinine concentration of 3.1+/-1.0 mg per deciliter [274.0+/-88.4 micromol per liter]). Hemofiltration (fluid replacement rate, 1000 ml per hour without weight loss) and saline hydration were initiated 4 to 8 hours before the coronary intervention and were continued for 18 to 24 hours after the procedure was completed. RESULTS: An increase in the serum creatinine concentration of more than 25 percent from the base-line value after the coronary intervention occurred less frequently among the patients in the hemofiltration group than among the control patients (5 percent vs. 50 percent, P<0.001). Temporary renal-replacement therapy (hemodialysis or hemofiltration) was required in 25 percent of the control patients and in 3 percent of the patients in the hemofiltration group. The rate of in-hospital events was 9 percent in the hemofiltration group and 52 percent in the control group (P<0.001). In-hospital mortality was 2 percent in the hemofiltration group and 14 percent in the control group (P=0.02), and the cumulative one-year mortality was 10 percent and 30 percent, respectively (P=0.01). CONCLUSIONS: In patients with chronic renal failure who are undergoing percutaneous coronary interventions, periprocedural hemofiltration given in an ICU setting appears to be effective in preventing the deterioration of renal function due to contrast-agent-induced nephropathy and is associated with improved in-hospital and long-term outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
The effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Solomon, R., Werner, C., Mann, D., D'Elia, J., & Silva, P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312104 · Cited by 1,254
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., Murphy, M. J., Halpern, E. F., Hill, J. A., Winniford, M., Cohen, M. B., VanFossen, D. B., et al. (1995) · Kidney International · doi:10.1038/ki.1995.32 · Cited by 923
Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., Perruchoud, A. P., Eriksson, U., Marsch, S., & Roskamm, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.329 · Cited by 806
Gruberg, L., Mintz, G. S., Mehran, R., Dangas, G., Lansky, A. J., Kent, K. M., Pichard, A. D., Satler, L. F., & Leon, M. B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00917-7 · Cited by 749
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Bellomo, R., Kellum, J. A., & Ronco, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61454-2 · Cited by 2,598
MEHRAN, R., AYMONG, E., NIKOLSKY, E., LASIC, Z., IAKOVOU, I., FAHY, M., MINTZ, G., LANSKY, A., MOSES, J., & STONE, G. (2004) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(04)01445-7 · Cited by 1,251
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
Endorsed by the European Society of Intensive Care Medicine (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi044 · Cited by 1,178
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Merten, G. J., Burgess, W. P., Gray, L. V., Holleman, J. H., Roush, T. S., Kowalchuk, G. J., Bersin, R. M., Van Moore, A., Simonton III, C. A., Rittase, R. A., et al. (2004) · JAMA · doi:10.1001/jama.291.19.2328 · Cited by 1,087
Contrast-Induced Acute Kidney Injury
McCullough, P. A., Choi, J. P., Feghali, G. A., Schussler, J. M., Stoler, R. M., Vallabahn, R. C., & Mehta, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.099 · Cited by 1,067
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines
on behalf of the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR), Stacul, F., van der Molen, A. J., Reimer, P., Webb, J. A. W., Thomsen, H. S., Morcos, S. K., Almén, T., Aspelin, P., Bellin, M.-F., et al. (2011) · European Radiology · doi:10.1007/s00330-011-2225-0 · Cited by 884
Contrast-Induced Acute Kidney Injury
McCullough, P. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.035 · Cited by 822
Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., Grazi, M., Veglia, F., & Bartorelli, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.043 · Cited by 737
Self-citationN -Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De Metrio, M., Galli, S., Fabbiocchi, F., Montorsi, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054209 · Cited by 611
Self-citationPreventing Nephropathy Induced by Contrast Medium
Barrett, B. J., & Parfrey, P. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050801 · Cited by 597
The ad-hoc working group of ERBP:, Fliser, D., Laville, M., Covic, A., Fouque, D., Vanholder, R., Juillard, L., & Van Biesen, W. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs375 · Cited by 573
Calzavacca, P., Licari, E., & Bellomo, R. (2010) · Surgical Intensive Care Medicine · doi:10.1007/978-0-387-77893-8_38 · Cited by 533
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification
Bartholomew, B. A., Harjai, K. J., Dukkipati, S., Boura, J. A., Yerkey, M. W., Glazier, S., Grines, C. L., & O'Neill, W. W. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.008 · Cited by 524
Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach
Tepel, M., Aspelin, P., & Lameire, N. (2006) · Circulation · doi:10.1161/circulationaha.105.595090 · Cited by 506
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
Prophylaxis Strategies for Contrast-Induced Nephropathy
Pannu, N., Wiebe, N., Tonelli, M., & Alberta Kidney Disease Network, F. T. (2006) · JAMA · doi:10.1001/jama.295.23.2765 · Cited by 410
Risks and Complications of Coronary Angiography: A Comprehensive Review
Tavakol, M., Ashraf, S., & Brener, S. J. (2011) · Global Journal of Health Science · doi:10.5539/gjhs.v4n1p65 · Cited by 380
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies
Goldenberg, I. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040847 · Cited by 375
Drug-associated renal dysfunction and injury
Choudhury, D., & Ahmed, Z. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0076 · Cited by 345
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies
Azzalini, L., Spagnoli, V., & Ly, H. Q. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.013 · Cited by 262
Strategies to Reduce the Risk of Contrast-Induced Nephropathy
Stacul, F., Adam, A., Becker, C. R., Davidson, C., Lameire, N., McCullough, P. A., & Tumlin, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.024 · Cited by 255
Metadata
- Authors
- Marenzi, G., Marana, I., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Trabattoni, D., Fabbiocchi, F., Montorsi, P., & Bartorelli, A. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-02
- Volume
- 349
- Issue
- 14
- Pages
- 1333-1340
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1971468596
- Cited by
- 504
- References
- 23
- FWCI
- 28.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.